Even more, ERK1/2 and AKT are also downstream mediators of PD-L1 expression, further suggesting that the immune response and tumor mutational alterations play a pivotal role in the development of a complex network of cytokine signaling that results in the expression of immunomodulatory molecules in cancer cells [36]. This evidence concerns the gene AKT1 and neoplasm.